Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display distinct ecology and are also likely to respond differently to treatment.
Quelle: ScienceDaily | COPD
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- New scan method unveils lung function secrets
- First new treatment for asthma attacks in 50 years
- New study shows promising results for COPD treatment
- Researchers develop robotic sensory cilia that monitor internal biomarkers to detect and assess airway diseases
- Experimental blood test predicts risk for developing COPD, other severe respiratory diseases
- Engineers design lookalike drug carrier to evade lung's lines of defense
- COPD and BPD: Inhalation of live Lactobacilli lessens lung inflammation and improves lung function
- Mucus-based bio-ink could be used to print and grow lung tissue
- New insights on polymicrobial infections in chronic lung diseases
- Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2 inflammation
